Tumor Protein p53
TP53proteinp53 promotes ferritinophagy-driven iron metabolism during myocardial ischemia and contributes to cardiomyocyte death and plaque instability.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationaleMediates ferritinophagy in myocardial injury; implicated in plaque rupture and cardiomyocyte apoptosis.
Also acts inCap degradation / rupture, Vascular inflammation
Druggability
DruggableYes
Known drugs / candidates9
Small-molecule tractableYes
Antibody tractableNo
EnsemblENSG00000141510
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(2)
- Multi-omics approach to personalised treatment: insights into thrombus-derived exosome regulation in cardiomyocyte ferritinophagy.Frontiers in immunology · 2025 · PMID 40948766 · doi
- Dynamic Changes in Plasma Urotensin II and Its Correlation With Plaque Stability.Journal of cardiovascular pharmacology · 2021 · PMID 34173803 · doi